Harm Reduction Care – Potential Cost-Savings Opportunities Related to the Delivery Model (Georgia).
WDI investigated how the cost of harm reduction services varied across health centers within the country of Georgia, and identified potential cost-saving opportunities related to the delivery model. Within Georgia’s current HIV/AIDS program, the Global Fund supports harm reduction services for injection drug users. However, Georgia is expected to fully transition to local financing of its HIV/AIDS and TB programs by 2022. In preparation for this transition, Georgia has been interested in identifying ways to reduce the cost of harm reduction services to ensure sustainability. While the focus of WDI’s work was harm reduction services in Georgia, the principles behind it are applicable to other partner countries, particularly to those that are transitioning. This work was done under WDI’s ongoing contract with the Global Fund.